2009Zhongguo linchuang jiepouxue zazhiRequires access

Experimental study on the effects of Resveratrol on cell cycle of HepG2 cells

Meizhi Wang

Open publisher page 1 citations

Abstract

Objective:To discuss the effects of Resveratrol(Res) on the growth and cell cycle of human hepatoblastoma-derived HepG2 cell line.Methods: HepG2 cells were exposed to Res at the different concentrations(0,25,50 and 100 μmol/L)for 24h,48h and 72h.Morphologic changes of cells were detected under the phasecontrast microscope.The cell cycle of HepG2 cell treated with Res were analyzed by flowcytometry.Cyclin dependent kinase 2(CDK2) and Cyclin E expression level were tested by flowcytometry.Results: Res could significantly inhibit proliferation of HepG2 and cause the increase of cells in the S phase,G2/M and a corresponding decrease of cells in the G0/G1 phase.Expression level of CDK2 and Cyclin E were also increased in treated cells with a dose-dependent manner.Conclusions: Res will inhibit the proliferation of HepG2 in vitro,by inducing cell blockage at G0/G1 stage,which maybe resulted from the inactivation of CDK2 and Cyclin E.

About this research paper

What this paper is about

Objective:To discuss the effects of Resveratrol(Res) on the growth and cell cycle of human hepatoblastoma-derived HepG2 cell line.Methods: HepG2 cells were exposed to Res at the different concentrations(0,25,50 and 100 μmol/L)for 24h,48h and 72h.Morphologic changes of cells were detected under the phasecontrast microscope.The cell cycle of HepG2 cell treated with Res were analyzed by flowcytometry.Cyclin dependent kinase 2(CDK2) and Cyclin E expression level were tested by flowcytometry.Results: Res could significantly inhibit proliferation of HepG2 and cause the increase of cells in the S phase,G2/M and a corresponding decrease of cells in the G0/G1 phase.Expression level of CDK2 and Cyclin E were also increased in treated cells with a dose-dependent manner.Conclusions: Res will inhibit the proliferation of HepG2 in vitro,by inducing cell blockage at G0/G1 stage,which maybe resulted from the inactivation of CDK2 and Cyclin E.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To discuss the effects of Resveratrol(Res) on the growth and cell cycle of human hepatoblastoma-derived HepG2 cell line.Methods: HepG2 cells were exposed to Res at the different concentrations(0,25,50 and 100 μmol/L)for 24h,48h and 72h.Morphologic changes of cells were detected under the phasecontrast microscope.The cell cycle of HepG2 cell treated with Res were analyzed by flowcytometry.Cyclin dependent kinase 2(CDK2) and Cyclin E expression level were tested by flowcytometry.Results: Res could significantly inhibit proliferation of HepG2 and cause the increase of cells in the S phase,G2/M and a corresponding decrease of cells in the G0/G1 phase.Expression level of CDK2 and Cyclin E were also increased in treated cells with a dose-dependent manner.Conclusions: Res will inhibit the proliferation of HepG2 in vitro,by inducing cell blockage at G0/G1 stage,which maybe resulted from the inactivation of CDK2 and Cyclin E.

Key concepts: Cell cycle, Cyclin-dependent kinase 2, Cyclin E, Resveratrol, Cell biology, Chemistry, Cell growth, Hepatoblastoma

Related papers

Back to paper searchBrowse research topicsOriginal source
Experimental study on the effects of Resveratrol on cell cycle of HepG2 cells — Research Paper | ScholarLens